Related Experiment Video
Updated: Mar 6, 2026

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia
Published on: February 3, 2023
Genetics of primary sclerosing cholangitis and pathophysiological implications.
Xiaojun Jiang1,2,3,4, Tom H Karlsen1,2,3,4
1Norwegian PSC Research Center, Department of Transplantation Medicine, Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital Rikshospitalet, Postbox 4950Nydalen, 0424 Oslo, Norway.
Genetic studies reveal key factors in primary sclerosing cholangitis (PSC) pathogenesis, identifying shared features with autoimmune diseases and inflammatory bowel disease (IBD). This advances understanding for potential new therapies.
Area of Science:
- Genetics
- Immunology
- Gastroenterology
Background:
- Primary sclerosing cholangitis (PSC) is a chronic fibrotic disease of bile ducts, leading to significant morbidity and mortality.
- PSC is associated with cholestatic liver cirrhosis, inflammatory bowel disease (IBD), and increased risk of bile duct cancer.
- Genetic factors are crucial for understanding PSC pathogenesis and developing effective treatments.
Purpose of the Study:
- To review genetic discoveries in PSC pathogenesis.
- To interpret gene findings within established PSC disease models.
- To propose translational research for novel therapeutic insights.
Main Methods:
- Genome-wide association studies (GWAS) have been instrumental in identifying disease susceptibility genes.
- Analysis of human leukocyte antigen (HLA) associations.
- Review of existing literature and disease models.
Main Results:
- Numerous PSC susceptibility genes have been identified through genetic studies.
- The genetic architecture of PSC shows overlap with autoimmune diseases and IBD.
- Strong HLA associations and T-cell-related genes suggest adaptive immune involvement.
Conclusions:
- Genetic findings position PSC as an autoimmune disease.
- Understanding genetic underpinnings is key to developing targeted therapies.
- Further translational research is needed to leverage genetic insights for patient benefit.
Related Concept Videos
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation

